Can leucovorin (folinic acid) be used after the vial has been opened?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Leucovorin (folinic acid) should be used immediately after opening the vial, and any unused portion should be discarded. Once reconstituted, leucovorin solution is typically stable for only 24 hours when refrigerated at 2-8°C (36-46°F) 1. The stability of opened vials varies by manufacturer and formulation, so always check the specific product information. Leucovorin is sensitive to light and can degrade when exposed to air and light, potentially reducing its efficacy. This degradation occurs because leucovorin is a reduced folate that can oxidize when exposed to environmental factors. For patient safety, it's essential to follow aseptic technique when handling the medication, and if the solution appears discolored or contains particles, it should not be used. If you need to store reconstituted leucovorin, keep it in the refrigerator in a light-resistant container, clearly labeled with the date and time of reconstitution to ensure it's used within the appropriate timeframe. Some key points to consider when handling leucovorin include:

  • Always check the specific product information for stability and storage guidelines
  • Use aseptic technique when handling the medication
  • Discard any unused portion after reconstitution
  • Store reconstituted leucovorin in the refrigerator in a light-resistant container
  • Label the container with the date and time of reconstitution
  • Monitor the solution for signs of degradation, such as discoloration or particles, and discard if necessary. It's also important to note that the provided studies 2, 3, 4, 5, 1 do not directly address the stability of leucovorin after opening, but they do provide information on the use of leucovorin in patients with methotrexate-induced renal dysfunction, which can inform handling and administration practices.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.